SEC Form 4 · accession 0001209191-18-036092
STERIS plc · STE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Loyal W Wilson
Director
Period of report
Jun 5, 2018
Accepted (ET)
Jun 6, 2018 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001624899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, 10 pence par value | Jun 5, 2018 | M | 3,609 | $28.08 | A | 32,765 | D | |
| Ordinary Shares, 10 pence par valueF1 | Jun 5, 2018 | S | 3,609 | $105.16 | D | 29,156 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F2 | $28.08 | Jun 5, 2018 | M | 3,609 | D | — | Jul 31, 2019 | Ordinary Shares | 3,609 | 0 | D |
Explanation of responses
- F1This represents the average sales price of the 3,609 shares sold in the open market. The actual sales prices ranged from $105.16 per share to $105.18 per share. The Reporting Person, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of the separate sales prices.
- F2This option to purchase 3,609 STERIS plc ordinary shares, which is fully vested, was received in conjunction with the "Combination" of STERIS Corporation and Synergy Health, Ltd. in exchange for an option to purchase 3,609 STERIS Corporation common shares for $28.08 per share, subject to the same terms and conditions as the original STERIS Corporation stock option.